Associations of cytokine genes with Alzheimer's disease and depression in an elderly Korean population

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 9, 2015, Pages 1002-1007

  Kang, Hee Ju ^a   Kim, Jae Min ^a   Kim, Sung Wan ^a   Shin, Il Seon ^a   Park, Sung Woo ^b   Kim, Young Hoon ^b   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COMMUNITY LIVING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; DNA POLYMORPHISM; EDUCATIONAL STATUS; FEMALE; GENDER AND SEX; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IL 10 GENE; IL 1BETA GENE; IL 4 GENE; IL 6 GENE; IL 8 GENE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TNF ALPHA GENE; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOKINES; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940705901     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-308469     Document Type: Article

References (40)

1. Caraci F, Copani A, Nicoletti F, et al. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 2010;626:64-71.
2. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
3. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012;36:764-85.
4. Rojo LE, Fernández JA, Maccioni AA, et al. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res 2008;39:1-16.
5. McCusker SM, Curran MD, Dynan KB, et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001;357:436-9.
6. Gnjec A, D'Costa KJ, Laws SM, et al. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. J Neuroinflammation 2008;5:36-45.
7. Hedley R, Hallmayer J, Groth DM, et al. Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann Neurol 2002;51:795-7.
8. Tedde A, Putignano AL, Nacmias B, et al. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort. Neurosci Lett 2008;446:139-42.
9. Rosenmann H, Meiner Z, Dresner-Pollak R, et al. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population. Neurosci Lett 2004;363:131-3.
10. Cerri AP, Arosio B, Viazzoli C, et al. The -308 (G/A) single nucleotide polymorphism in the TNF- α gene and the risk of major depression in the elderly. Int J Geriatr Psychiatry 2010;25:219-23.
11. Holtzman S, Abbey SE, Chan C, et al. A genetic predisposition to produce low levels of IL-10 is related to depressive symptoms: a pilot study of patients with end stage renal disease. Psychosomatics 2012;53:155-61.
12. Hwang JP, Tsai SJ, Hong CJ, et al. Interleukin-1 beta -511C/T genetic polymorphism is associated with age of onset of geriatric depression. Neuromolecular Med 2009;11:322-7.
13. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201-17.
14. Flex A, Giovannini S, Biscetti F, et al. Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease. Neurodegener Dis 2014;13:230-6.
15. Kim JM, Stewart R, Kim SW, et al. Changes in folate, vitamin B12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry 2008;79:864-8.
16. Park JH, Kwon YC. Modification of the mini-mental state examination for use in the elderly in a non-western society: part I. development of Korean version of Mini-Mental State Examination. Int J Geriatr Psychiatry 1990;5:381-7.
17. Lawton MP, Brody EM. Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist 1969;9:179-86.
18. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72.
19. th edn. Washington DC: American Psychiatric Press, 1994.
20. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-44.
21. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINCDS-AIREN International Work Group. Neurology 1993;43:250-60.
22. Copeland JRM, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 1986;16:89-99.
23. Kim JM, Stewart R, Prince M, et al. Diagnosing dementia in a developing nation: an evaluation of the GMS-AGECAT algorithm in an older Korean population. Int J Geriatr Psychiatry 2003;18:331-6.
24. Vasto S, Candore G, Listì F, et al. Inflammation, genes and zinc in Alzheimer's disease. Brain Res Rev 2008;58:96-105.
25. Penninx BW, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003;54:566-72.
26. Lou XY, Chen GB, Yan L, et al. A generalized combinational approach for detecting gene-by-gene and gene-by-environment interactions with application to Nicotine dependence. Am J Hum Genet 2007;80:1125-37.
27. Swardfager W, Lanctôt K, Rothenburg L, et al. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 2010;68:930-41.
28. de Craen AJ, Posthuma D, Remarque EJ, et al. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005;6:167-70.
29. Yang L, Lu R, Jiang L, et al. Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population. Brain Res 2009;1247:178-81.
30. Di Bona D, Candore G, Franceschi C, et al. Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev 2009;61:60-8.
31. Wehr H, Bednarska-Makaruk M, Lojkowska W, et al. Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia Dement. Geriatr Cogn Disord 2006;22:1-7.
32. Vendramini AA, de Lábio RW, Rasmussen LT, et al. Interleukin-8-251T > A, interleukin-1α-889C > T and apolipoprotein E polymorphisms in Alzheimer's disease. Genet Mol Biol 2011;34:1-5.
33. Milaneschi Y, Corsi AM, Penninx BW, et al. Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study. Biol Psychiatry 2009;65:973-8.
34. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-57.
35. Jun TY, Pae CU, Hoon H, et al. Possible association between -G308A tumour necrosis factor-α gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet 2003;13:179-81.
36. Misener VL, Gomez L, Wigg KG, et al. Cytokine genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology 2008;58:71-80.
37. Rosa A, Peralta V, Papiol S, et al. Interleukin-1β (IL-1β) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 2004;124B:10-14.
38. McCulley MC, Day IN, Holmes C. Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2004;124B:50-3.
39. Yu YW, Chen TJ, Hong CJ, et al. Association study of the interleukin-1β (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003;28:1182-5.
40. Otte C, McCaffery J, Ali S, et al. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 2007;164:1379-84.